Expert Opinion on Emerging Drugs Template
Get your Expert Opinion on Emerging Drugs paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.9
How to Use the Expert Opinion on Emerging Drugs Template | A Step-by-Step Guide
Authored by Sumalatha Gangadhar | Published on 11 August, 2026
Submitting to Expert Opinion on Emerging Drugs goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Expert Opinion on Emerging Drugs guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
What is the Expert Opinion on Emerging Drugs Template?
It is a manuscript shell aligned to Expert Opinion on Emerging Drugs. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Expert Opinion on Emerging Drugs journal page before you draft.
What's actually in an Expert Opinion on Emerging Drugs submission:
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Expert Opinion on Emerging Drugs guide for authors lists, and cite figures and tables in order.
What separates a clean submission from one that gets kicked back:
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Expert Opinion on Emerging Drugs guide for authors before you submit.
What does this Expert Opinion on Emerging Drugs Template include?
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
Steps to Use This Template with SciSpace Agent
- Click Start Writing on this page. The SciSpace Agent prompt screen opens with the template loaded.
- Use the loaded template, or upload a version your group already uses for Expert Opinion on Emerging Drugs.
- Edit the prompt with your topic and article type, and note any requirement from the Expert Opinion on Emerging Drugs guide for authors.
- Run the prompt. The agent drafts into the correct structure and reference style.
- Use View Outputs to verify required statements and formatting are present.
- Export and submit through the journal's submission system.
Expert Opinion on Emerging Drugs Template Structure at a Glance
| Element | Expert Opinion on Emerging Drugs requirement |
|---|---|
| Abstract | Structured abstract required with maximum 200 words. Mandatory headings: 1) Introduction (authors describe the significance of the topic under discussion), 2) Areas covered (authors describe the research discussed and the literature search undertaken), 3) Expert Opinion/Commentary (authors summarize briefly their Expert Opinion section). References must not be included in the abstract. Clinical trial registration numbers must be included if applicable |
| Main text | Review Articles: 5,000-7,000 words (not including figures, tables or references). Up to five figures and five tables are permitted. Must include sections: Background, Medical need, Existing treatment, Market review, Current research goals, Scientific rationale, Competitive environment, Potential development issues, Conclusion, and Expert Opinion |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | 5-8 keywords required, in alphabetical order |
| References | Taylor & Francis Standard NLM style. Papers or patents of particular interest should be identified using asterisks (* = of interest, ** = of considerable interest) and annotated with a brief sentence explaining why the reference is considered to be of interest. A maximum of 100 references is suggested for Review Articles |
| Peer review | Double-blind (double-anonymous) peer review by at least two independent, anonymous expert referees |
| Submission | rp.tandfonline.com/submission/create?journalCode=IEMD |
Quick Tips for Using the Expert Opinion on Emerging Drugs Template
Read the Expert Opinion on Emerging Drugs guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Expert Opinion on Emerging Drugs in under a page.
Best Practices
Skim two or three recent Expert Opinion on Emerging Drugs papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Expert Opinion on Emerging Drugs journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Before You Submit: Final Check
Do one focused pass against the Expert Opinion on Emerging Drugs guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.
